Pictet Asset Management Holding Sa Intra Cellular Therapies, Inc. Transaction History

Pictet Asset Management Holding Sa

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 05, 2025	SELL	$81.78 - $131.92 $123 Million - $198 Million	-1,499,444 Reduced 97.34%	41,041 $5.41 Million
Q4 2024 Feb 12, 2025	SELL	$71.19 - $91.57 $5.61 Million - $7.21 Million	-78,783 Reduced 4.87%	1,540,485 $129 Million
Q3 2024 Nov 12, 2024	BUY	$67.99 - $80.84 $24.8 Million - $29.4 Million	364,192 Added 29.02%	1,619,268 $118 Million
Q2 2024 Aug 13, 2024	BUY	$64.76 - $79.84 $28.1 Million - $34.7 Million	434,546 Added 52.96%	1,255,076 $86 Million
Q1 2024 May 14, 2024	SELL	$64.37 - $75.65 $33.1 Million - $38.9 Million	-514,213 Reduced 38.53%	820,530 $56.8 Million
Q4 2023 Feb 13, 2024	SELL	$46.37 - $73.65 $19.1 Million - $30.4 Million	-412,917 Reduced 23.63%	1,334,743 $95.6 Million
Q3 2023 Nov 14, 2023	BUY	$52.09 - $64.1 $91 Million - $112 Million	1,747,660 New	1,747,660 $91 Million

12.3M

600

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $12.4B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

Get notified when there are updates to the investment portfolio of Pictet Asset Management Holding Sa, based on Form 13F filings with the SEC.

Stay updated on Pictet Asset Management Holding Sa with notifications on news.